Completion of Patient Enrollment, PI Study of MultiStem, Athersys (ATHX)
January 7th, 2011
No comments
ATHX has completed patient enrollment of the single dose arm of a clinical study involving administration of MultiStem(R) Read more…
Categories: NASDAQ: ATHX, PI Study of MultiStem, Stem Cell Technology
